• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝炎诊断——一种基于模型的个性化医学方法。

Nonalcoholic Steatohepatitis Diagnosis - A Model-Related Personalized Medicine Approach.

机构信息

Inserm URMS 1142, Sorbonne University, Paris- France.

Public Health Departement, North-East Parisian Hospitals, France.

出版信息

Stud Health Technol Inform. 2022 Nov 3;299:191-195. doi: 10.3233/SHTI220982.

DOI:10.3233/SHTI220982
PMID:36325862
Abstract

Nonalcoholic fatty liver disease (NAFLD) is a clinical syndrome, and pathologically characterized by diffuse macro-vesicular fatty change in the hepatocytes. NAFLD includes simple nonalcoholic fatty liver disease, nonalcoholic steatohepatitis (NASH) and hepatic cirrhosis. NASH is a disease evolving under the influence of various stimuli still poorly understood, but where insulin resistance is prominently. In this paper, we present a new diagnosis model to predict NASH.

摘要

非酒精性脂肪性肝病(NAFLD)是一种临床综合征,病理学特征为肝细胞弥漫性大泡性脂肪变。NAFLD 包括单纯性非酒精性脂肪肝、非酒精性脂肪性肝炎(NASH)和肝硬化。NASH 是一种在各种刺激因素影响下发展的疾病,其机制仍不完全清楚,但胰岛素抵抗是突出的。本文提出了一种新的 NASH 预测诊断模型。

相似文献

1
Nonalcoholic Steatohepatitis Diagnosis - A Model-Related Personalized Medicine Approach.非酒精性脂肪性肝炎诊断——一种基于模型的个性化医学方法。
Stud Health Technol Inform. 2022 Nov 3;299:191-195. doi: 10.3233/SHTI220982.
2
Histopathological Diagnosis of Nonalcoholic Steatohepatitis (NASH).非酒精性脂肪性肝炎(NASH)的组织病理学诊断。
Methods Mol Biol. 2022;2455:1-18. doi: 10.1007/978-1-0716-2128-8_1.
3
Pathologic Diagnosis of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的病理诊断。
Arch Pathol Lab Med. 2022 Aug 1;146(8):940-946. doi: 10.5858/arpa.2021-0339-RA.
4
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.与健康正常体重个体相比,不同程度非酒精性脂肪性肝病患者的肝转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17.
5
Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?非酒精性脂肪性肝病的无创诊断:我们做到了吗?
Metabolism. 2016 Aug;65(8):1087-95. doi: 10.1016/j.metabol.2016.01.013. Epub 2016 Feb 2.
6
[Research progress of omics biomarkers for nonalcoholic fatty liver disease].[非酒精性脂肪性肝病的组学生物标志物研究进展]
Zhonghua Gan Zang Bing Za Zhi. 2021 Jun 20;29(6):604-608. doi: 10.3760/cma.j.cn501113-20200708-00382.
7
The role of noninvasive tests and liver biopsy in the diagnosis of nonalcoholic fatty liver disease.非侵入性检查和肝活检在非酒精性脂肪性肝病诊断中的作用。
J Med Life. 2018 Jul-Sep;11(3):243-246. doi: 10.25122/jml-2018-1002.
8
The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.美国生活方式引起的肥胖综合征饮食在雄性和雌性啮齿动物中再现了非酒精性脂肪性肝病和非酒精性脂肪性肝炎的临床和转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2020 Sep 1;319(3):G345-G360. doi: 10.1152/ajpgi.00055.2020. Epub 2020 Aug 5.
9
Noninvasive diagnosis of nonalcoholic steatohepatitis disease based on clinical decision support system.基于临床决策支持系统的非酒精性脂肪性肝炎疾病的无创诊断
Stud Health Technol Inform. 2013;192:1178.
10
[Histopathological diagnosis and differential diagnosis of nonalcoholic fatty liver disease].非酒精性脂肪性肝病的组织病理学诊断与鉴别诊断
Pathologe. 2020 Sep;41(5):434-443. doi: 10.1007/s00292-020-00800-0.